These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 9820054

  • 21. Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study.
    Fernández R, Puig JG, Rodríguez-Pérez JC, Garrido J, Redon J, TRAVEND Study Group.
    J Hum Hypertens; 2001 Dec; 15(12):849-56. PubMed ID: 11773987
    [Abstract] [Full Text] [Related]

  • 22. Once-daily monotherapy with trandolapril in the treatment of hypertension.
    Smith DH, Neutel JM, Black HR, Schoenberger JA, Weber MA.
    J Hum Hypertens; 1996 Feb; 10(2):129-34. PubMed ID: 8867568
    [Abstract] [Full Text] [Related]

  • 23. Verapamil SR/trandolapril combination therapy for the elderly hypertensive patient. German VeraTran Hypertension Study Group.
    Holzgreve H, Compagnone D, Zilles P.
    J Hum Hypertens; 1999 Jan; 13(1):61-7. PubMed ID: 9928754
    [Abstract] [Full Text] [Related]

  • 24. Comparison of the efficacy and safety of trandolapril and nifedipine SR in mild-to-moderate hypertension. Investigator Study Group.
    Steiner G, Pauly NC.
    J Cardiovasc Pharmacol; 1994 Jan; 23 Suppl 4():S81-5. PubMed ID: 7527108
    [Abstract] [Full Text] [Related]

  • 25. [The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension].
    Widimský J.
    Vnitr Lek; 2009 Feb; 55(2):123-30. PubMed ID: 19348394
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of a new long-acting drug combination, trandolapril/verapamil as compared to monotherapy in primary hypertension. Swedish TARKA trialists.
    Karlberg BE, Andrup M, Odén A.
    Blood Press; 2000 Feb; 9(2-3):140-5. PubMed ID: 10855738
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
    Zheng S, Nath V, Coyne DW.
    Am J Nephrol; 2007 Feb; 27(5):522-9. PubMed ID: 17700014
    [Abstract] [Full Text] [Related]

  • 31. Verapamil SR and trandolapril combination therapy in hypertension--a clinical trial of factorial design. German Hypertension Study Group.
    Scholze J, Zilles P, Compagnone D.
    Br J Clin Pharmacol; 1998 May; 45(5):491-5. PubMed ID: 9643623
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 33. Influence of a history of arterial hypertension and pretreatment blood pressure on the effect of angiotensin converting enzyme inhibition after acute myocardial infarction. Trandolapril Cardiac Evaluation Study.
    Gustafsson F, Køber L, Torp-Pedersen C, Per Hildebrandt.
    J Hypertens Suppl; 1998 Jan; 16(1):S65-70. PubMed ID: 9534100
    [Abstract] [Full Text] [Related]

  • 34. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 35. [Spirapril in the therapy of mild and moderately severe hypertension. A Czech and Slovak multicenter study].
    Widimský J, Lánská V, Hulínský V.
    Vnitr Lek; 1995 Nov; 41(11):744-52. PubMed ID: 8553592
    [Abstract] [Full Text] [Related]

  • 36. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [Abstract] [Full Text] [Related]

  • 37. Blood pressure control rates with an antihypertensive regimen including trandolapril in a Canadian usual-care setting.
    Tytus RH, Assouline L, Vanjaka A.
    Adv Ther; 2011 Sep; 28(9):789-98. PubMed ID: 21850512
    [Abstract] [Full Text] [Related]

  • 38. Effectiveness of a trandolapril-based treatment regimen in subjects with isolated systolic hypertension in Canada.
    Tytus RH, Burgess ED, Assouline L, Vanjaka A.
    Curr Med Res Opin; 2009 Jun; 25(6):1379-84. PubMed ID: 19422278
    [Abstract] [Full Text] [Related]

  • 39. Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension. Trandolapril Study Group.
    DeQuattro V, Lee D.
    Am J Hypertens; 1997 Jul; 10(7 Pt 2):138S-145S. PubMed ID: 9231890
    [Abstract] [Full Text] [Related]

  • 40. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.